|Grade Standard||Medicine Grade|
|Pack Size||1 strip of 10 tablet|
- For the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
Renal Transplantation :
A dose of 1 g administered orally twice a day (daily dose of 2 g) is recommended for use in renal transplant patients. Pediatrics :
Patients with a body surface area of 1.25 m² to 1.5 m² (3 months to 18 years) may be given a dose of 750 mg twice daily (1.5 g daily dose). Patients with a body surface area > 1.5 m² may be dosed with at a dose of 1 g twice daily (2 g daily dose).Cardiac Transplantation :Adults :
A dose of 1.5g BID oral (daily dose of 3g) is recommended for use in adult cardiac transplant patients.Hepatic TransplantationAdults :
A dose of 1.5g BID oral (daily dose of 3g) is recommended for use in adult cardiac transplant patients.Dosage Adjustment :Renal Impairment :
Not required.Hepatic Impairment :
May be required in renal patients with some hepatic diseases.